1-8 of 8
Alisa B. Lee-Sherick
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MerTK Receptor Tyrosine Kinase Inhibition As a Potential Strategy to Augment Immune-Mediated Clearance of Acute Myeloid Leukemia

Lauren Shelby Page, BS, Xiaodong Wang, PhD, H. Shelton Earp, III, MD, Stephen Frye, PhD, Craig T Jordan, PhD, Alisa B. Lee-Sherick, MD
Journal: Blood
Blood (2016) 128 (22): 4044.
https://doi.org/10.1182/blood.V128.22.4044.4044
Published: 2016
Journal Articles

A Dominant Negative Mutation (p.P214L) in ETV6 is Associated with Megakaryocyte and Erythroid Transcript Misregulation

Leila Noetzli, BS, Jesse W Rowley, PhD, Michael U Callaghan, MD, Madhvi Rajpurkar, MD, Alisa B. Lee-Sherick, MD, Christopher C. Porter, MD, Andrew S. Weyrich, PhD, Jorge A. Di Paola, MD
Journal: Blood
Blood (2015) 126 (23): 76.
https://doi.org/10.1182/blood.V126.23.76.76
Published: 2015
Journal Articles

MRX2843, a Novel Dual MerTK-FLT3 Inhibitor with Activity Against Resistance-Conferring FLT3 Mutations in Acute Myeloid Leukemia

Katherine A Minson, MD, Catherine C Smith, MD, Alisa B. Lee-Sherick, MD, Deborah DeRyckere, PhD, Elisabeth Lasater, PhD, Amanda A. Hill, Xiaodong Wang, PhD, Stephen V. Frye, PhD, H. Shelton Earp, MD, Neil P. Shah, MD PhD, Douglas K. Graham, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3757.
https://doi.org/10.1182/blood.V124.21.3757.3757
Published: 2014
Journal Articles

UNC2025, a Small Molecule MerTK and Flt3 Tyrosine Kinase Inhibitor, Decreases Disease Burden, Prolongs Survival, and Promotes Sensitivity to Chemotherapy in Xenograft Models of Acute Leukemia

Deborah DeRyckere, PhD, Alisa B. Lee-Sherick, MD, Amanda A. Hill, Lauren Page, BS, Xiaodong Wang, PhD, Stephen V. Frye, PhD, H. Shelton Earp, MD, Douglas K. Graham, MD PhD
Journal: Blood
Blood (2014) 124 (21): 998.
https://doi.org/10.1182/blood.V124.21.998.998
Published: 2014
Journal Articles

UNC1666, a Dual Mer and Flt-3 Tyrosine Kinase Small Molecule Inhibitor In Acute Myeloid Leukemia

Alisa B. Lee-Sherick, MD, Kelly Menachof, Amanda A Hill, Sean Rinella, MPH, Jing Liu, Deborah DeRyckere, Xiaodong Wang, Stephen V Frye, H. Shelton Earp, III, Douglas K. Graham, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3849.
https://doi.org/10.1182/blood.V122.21.3849.3849
Published: 2013
Journal Articles

Mer receptor tyrosine kinase is a therapeutic target in pre–B-cell acute lymphoblastic leukemia

Rachel M. A. Linger, Alisa B. Lee-Sherick, Deborah DeRyckere, Rebecca A. Cohen, Kristen M. Jacobsen, Amy McGranahan, Luis N. Brandão, Amanda Winges, Kelly K. Sawczyn, Xiayuan Liang, Amy K. Keating, Aik Choon Tan, H. Shelton Earp, Douglas K. Graham
Journal: Blood
Blood (2013) 122 (9): 1599–1609.
https://doi.org/10.1182/blood-2013-01-478156
Published: 2013
Includes: Supplemental data
Journal Articles

Mer Receptor Tyrosine Kinase Is A Potential Therapeutic Target in Acute Myeloid Leukemia

Alisa B. Lee-Sherick, MD, Kelly Menachof, Kristen M. Eisenman, MD, Amy McGranahan, Colleen McGary, Sally A. Hunsucker, PhD, Jennifer Schlegel, Paul M Armistead, MD, PhD, Xiayuan Liang, MD, Dmitri Kireev, William Janzen, Jing Liu, Michael Stashko, Jacqueline Norris-Drouin, H. Shelton Earp, III, Xiaodong Wang, Stephen Frye, Deborah DeRyckere, PhD, Douglas K. Graham, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1317.
https://doi.org/10.1182/blood.V120.21.1317.1317
Published: 2012
Journal Articles

Mer Receptor Tyrosine Kinase Is Over-Expressed In and Contributes to Oncogenesis In Acute Myeloid Leukemia

Alisa B. Lee-Sherick, MD, Kristen M. Eisenman, MD, Susan Sather, BS, Deborah DeRyckere, PhD, Jennifer Schlegel, Douglas K. Graham, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1390.
https://doi.org/10.1182/blood.V118.21.1390.1390
Published: 2011